Ayumi Pharmaceutical

Tokyo, Japan Founded: 2015 • Age: 11 yrs Acquired By GNI Group
Specialty generic drugs for rheumatism and orthopedics are manufactured.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Ayumi Pharmaceutical

Ayumi Pharmaceutical was founded in 2015 in Tokyo, Japan, within the pharmaceutical sector. Generic products are manufactured, with operations centered on therapeutic areas including rheumatism and orthopedics. Focus is placed on specialty drugs for these fields, supporting healthcare needs in musculoskeletal conditions. The company is led from its base in Japan, contributing to the generics market.

  • Headquarter Tokyo, Japan
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Ayumi Pharmaceutical Corporation
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Blackstone

    & 1 more

  • Employee Count
    Not available
  • Acquired by
    GNI Group

    & 1 more

    (Jun 07, 2026)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Ayumi Pharmaceutical

Premium access

Detailed funding history for Ayumi Pharmaceutical

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Ayumi Pharmaceutical

Ayumi Pharmaceutical has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Blackstone and GNI Group.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Diversified investment management is provided across multiple asset classes.
Locked Locked Locked
Multinational company engaged in the research, development, & manufacturing of pharmaceutical drugs
Locked Locked Locked
Premium access

Investor details for Ayumi Pharmaceutical

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Ayumi Pharmaceutical

Investments
Premium access

Investment portfolio details for Ayumi Pharmaceutical

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Ayumi Pharmaceutical

Premium access

Detailed financials for Ayumi Pharmaceutical

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ayumi Pharmaceutical Comparisons

Ayumi Pharmaceutical Primary company
Description
Specialty generic drugs for rheumatism and orthopedics are m...
Location
Tokyo, Japan
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Ayumi Pharmaceutical

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Ayumi Pharmaceutical

Premium access

Detailed competitors of Ayumi Pharmaceutical

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ayumi Pharmaceutical

Blackstone’s Acquisition AYUMI Pharmaceutical
Global Legal Chronicle7 years ago
Blackstone belatedly buys into Abenomics
Business Medical Dialogues7 years ago
Premium access

Complete news archive for Ayumi Pharmaceutical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ayumi Pharmaceutical

Ayumi Pharmaceutical was founded in 2015.

Ayumi Pharmaceutical is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.

Kiyoaki Karasawa is the current CEO of Ayumi Pharmaceutical.

Ayumi Pharmaceutical was founded in 2015 in Tokyo, Japan, within the pharmaceutical sector. Generic products are manufactured, with operations centered on therapeutic areas including rheumatism and orthopedics. Focus is placed on specialty drugs for these fields, supporting healthcare needs in musculoskeletal conditions. The company is led from its base in Japan, contributing to the generics market.

Ayumi Pharmaceutical has 2 investors. Key investors include Blackstone, and GNI Group.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available